This article has been modified to add information from Sequenom's conference call.

NEW YORK (GenomeWEb) – Sequenom reported after the close of the market today that its third quarter 2015 revenues were down 21 percent compared to the third quarter of 2014.

The San Diego, California-based molecular diagnostics company had third quarter revenues totaling $29.9 million compared to $37.9 million in the third quarter 2014. It missed the Wall Street estimate of $31.4 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.